BRIEF-Greenwich Lifesciences Inc - Initiates New Us Clinical Sites For Flamingo-01 Phase Iii Trial

Reuters
Mar 19
BRIEF-<a href="https://laohu8.com/S/GLSI">Greenwich Lifesciences Inc</a> - Initiates New Us Clinical Sites For <a href="https://laohu8.com/S/FGO.AU">Flamingo</a>-01 Phase Iii Trial

March 19 (Reuters) - Greenwich Lifesciences Inc GLSI.O:

  • GREENWICH LIFESCIENCES INC - INITIATES NEW US CLINICAL SITES FOR FLAMINGO-01 PHASE III TRIAL

  • GREENWICH LIFESCIENCES INC - FLAMINGO-01 PHASE III TRIAL ACTIVATED AT CITY OF HOPE NETWORK SITES

  • GREENWICH LIFESCIENCES INC - FLAMINGO-01 TRIAL SITES COULD INCREASE TO 190-200 FROM CURRENT 160

Source text: ID:nGNX766qnf

Further company coverage: GLSI.O

((((Reuters.Briefs@thomsonreuters.com;));))

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10